Developer docs
API playgroundTry for free, no card

Search company profiles

ZenoWell

Full company profile

uuid00514gx

Namestring
ZenoWell
Legal namestring
ZENOWELL LIMITED
Websiteurl
zenowell.ai
Company typeenum
Private
Founded yearstring
-
Descriptiontext

ZenoWell is a private neurotechnology company that designs, manufactures, and sells wearable transcutaneous auricular vagus nerve stimulation (taVNS) devices for consumer wellness use. Its core products, the ZenoWell Luna ($409-$499) and ZenoWell Vita ($269-$479), are handheld controllers paired with electrode earpieces that target the auricular branch of the vagus nerve through two innervation-rich sites in the ear (cymba conchae and cavum concha), a configuration the company claims differentiates it from single-site competitors. The technology originated in Prof. Hocher's lab at Heidelberg University and is supported by an in-house research platform called BrainCLOS, developed with Swiss partner BEE Medic, which is used in studies at Cambridge, Heidelberg, and Charité Berlin.

The company monetizes primarily through one-time hardware sales via its own e-commerce storefront (zenowell.ai) with global shipping to the EU, UK, and selected international destinations, supplemented by recurring consumables revenue from replacement electrode earpieces ($129) and conductive gel packs ($59 for a five-month supply). Devices operate standalone without an app or subscription, and the company relies on a multi-channel GTM motion spanning DTC e-commerce, trade shows (CES, IFA, DGPPN, ACAN), community-led education through the Vagus Nerve Society and monthly webinars, and earned media partnerships with outlets including Vogue Italia and Cybernews.

Operationally, ZenoWell is structured as ZENOWELL LIMITED, registered in Hong Kong, with engineering and R&D teams in Heidelberg, Berlin, Shenzhen, and Hong Kong, and research collaborations extending to Stanford. The company holds CE, FCC, and RoHS certifications, reports 2M+ patient sessions with zero serious adverse events in referenced clinical trials, and is led by co-founders Jo Xue (CEO), Dr. Jane Xiao (Chief Scientist), and Prof. Berthold Hocher (Initiator), backed by a scientific advisory board drawn from Heidelberg, Charité, Cambridge, Harvard, Stanford, and CUHK. The most significant recent strategic action is a 2026 cooperation agreement with USound to integrate ultrasound-based physiological sensing into next-generation ear-worn devices, signaling a planned shift from discrete stimulation sessions toward continuous biometric monitoring.

Short descriptiontext

ZenoWell designs and sells wearable non-invasive auricular vagus nerve stimulation (taVNS) devices (Luna, Vita) for consumer wellness, targeting sleep, stress, pain, and recovery, and sells globally direct-to-consumer with consumables-based recurring revenue.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersPotsdam, Germany
HQ citystring
Potsdam
HQ countrystring
Germany
HQ regionstring
Europe
Markets served

Serves global market

Offices6 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
vagus nerve stimulation, wearable neurotechnology, auricular stimulation devices, non-invasive neuromodulation, wellness electronics
Industry2 codes
PRIMARYCRACAQAL
Mental Wellness & Stress Management Devices (Biofeedback, Meditation/Neurostimulation Devices)
Consumer Products & Retail/Consumer Electronics & Appliances Retail/Personal Health & Wellness Devices (Smart Scales, BP/ECG Monitors, Sleep Devices)
SECONDARYCRACAQAK
Posture, Musculoskeletal & Pain-Relief Devices (Posture Trainers, TENS/EMS, Massage Devices)
Consumer Products & Retail/Consumer Electronics & Appliances Retail/Personal Health & Wellness Devices (Smart Scales, BP/ECG Monitors, Sleep Devices)
NAICS code1 code
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
SIC code1 code
  • Electromedical & Electrotherapeutic Apparatus3845
Product category
Wearable Neurotechnology Devices
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model2 records
1Hardware Device Sales
TypeHardware Sales
Description

One-time purchase of taVNS devices (Luna and Vita) with no ongoing subscription required. Standalone operation without app dependency. Accessory purchases for consumables and replacements

zenowell.ai
2Accessories and Consumables
TypeHardware Sales
Description

Replacement earpieces ($129), conductive gel packs ($59), warranty cards. Ongoing revenue from consumables with 5-month supply cycle per gel pack

zenowell.ai
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations
Pricing details5 tiers
1ZenoWell Vita - Entry-level taVNS device
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

$269 (sale) / $479 (regular). Includes device, left earpiece, spray bottle, gel tube, charging cable, user manual, quick start guide, vagus nerve regulation activities, and warranty card. 4-hour battery, 12 sessions per charge. Retro-tech style with clean lines.

zenowell.ai
2ZenoWell Luna - Advanced taVNS device
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

$409 (sale) / $499 (regular). Includes device, left earpiece, felt case. 8-hour battery, 24 sessions per charge. Smooth modern design with gentle curves. Four modes: Relief, Sleep, Relax, Medit.

zenowell.ai
3Electrode Earpiece - Replacement accessory
ModelUnit PricingBilling cadencePay-as-you-go
Notes

$129 per earpiece. Available for left ear, right ear, or rainbow limited edition.

zenowell.ai
4Gel Pack - Conductive gel consumable
ModelUnit PricingBilling cadencePay-as-you-go
Notes

$59 (sale) / $69 (regular). 3x50g gel tubes (5 month supply). Odorless formula with 3-year shelf life.

zenowell.ai
5Warranty Card Extension
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

$0 (included with January purchases). Extended warranty offer with VIP benefits including one-to-one coaching, ZenoCare gift, extra warranty, and 30-day refund period.

zenowell.ai
GTM typeB2C
B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 record
1BrainCLOS
Description

Research-grade vagus nerve stimulation system developed in collaboration with BEE Medic Switzerland, used in clinical studies at Cambridge University, Heidelberg University, and Charité Berlin

zenowell.ai
Core offering1 text field

ZenoWell designs, manufactures, and sells wearable non-invasive transcutaneous auricular vagus nerve stimulation (taVNS) devices — Luna (4 modes, $409 sale) and Vita (3 modes, $269 sale) — paired with proprietary electrode earpieces and conductive gel consumables. The devices stimulate the auricular branch of the vagus nerve via the ear to address sleep, stress, headache, fatigue, and recovery concerns. The company operates a direct-to-consumer e-commerce store (zenowell.ai) shipping globally with no subscription or app required for device operation.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 6 values shown
  • 25% deeper sleep, 45% less stress, 12% higher HRV, 30% less headache discomfort
+5 more records
Product overview1 text field

ZenoWell offers a portfolio of wearable non-invasive transcutaneous auricular vagus nerve stimulation (taVNS) devices. The core products are ZenoWell Luna and ZenoWell Vita, both handheld controller devices paired with electrode earpieces that stimulate the auricular branch of the vagus nerve through the ear. Luna features four modes (Relief, Sleep, Relax, Medit) with 8-hour battery life for headache, sleep, stress, and pain applications, while Vita offers three modes (Sleep, Relax, Meditation) with 4-hour battery life focused on sleep and relaxation. Both devices use conductive gel with their earpieces and are accompanied by consumable gel packs. The ecosystem is supported by the BrainCLOS research platform providing clinical-grade studies for healthcare professionals. The company originated from Heidelberg University and collaborates with institutions including Harvard and Cambridge.

Product and service3 records
1ZenoWell Luna
CategoryCore wearable device
Description

Advanced wearable non-invasive transcutaneous auricular vagus nerve stimulation (taVNS) device with four modes (Relief, Sleep, Relax, Medit) designed for headache relief, sleep improvement, stress reduction, and pain/fatigue management. Features 8-hour battery supporting 24 sessions and targets the auricular branch of the vagus nerve via a paired electrode earpiece.

2ZenoWell Vita
CategoryCore wearable device
Description

Wearable non-invasive transcutaneous auricular vagus nerve stimulation (taVNS) device with three modes (Sleep, Relax, Meditation) designed to enhance sleep, reduce stress and tension, and alleviate fatigue by stimulating the auricular branch of the vagus nerve. Features 4-hour battery supporting 12 sessions.

3ZenoWell Electrode Earpiece
Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership8 partners
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2026-03-26
Description

Strategic cooperation to explore integration of USound's advanced MEMS-based sensing technologies into next-generation wearable health devices. Collaboration aims to combine USound's ultrasound-based physiological sensing capabilities with ZenoWell's ear-based vagus nerve stimulation platform to enable continuous biometric monitoring for sleep, pain, anxiety, and mental health applications. USound holds over 500 patents protecting its MEMS loudspeaker and ultrasound sensing technology.

Strategic tierMinorTypeGTM or Marketing PartnerAnnounced on2026-01-01
Description

Partnership to promote GI health education during Gastroparesis Awareness Month. Collaborative educational initiatives for gut-brain axis awareness.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Collaboration to bring ZenoWell's vision to life. Together with BEE Medic, they launched the first research-grade system: BrainCLOS, which became part of studies at Cambridge University, Heidelberg University, and Charité Berlin.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Origin of ZenoWell technology from Prof. Hocher's lab at Heidelberg University. Ongoing research collaboration with academic institution.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Research collaboration with Charité University Medicine Berlin. Prof. Pommer from Charité is part of the scientific advisory board.

6Cambridge University
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Academic research collaboration with Cambridge University. Prof. Voon from Cambridge is part of the scientific advisory board.

zenowell.ai
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Affiliation with Vagus Nerve Society (vnsociety.org) for professional networking and knowledge sharing in the VNS field.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Research collaboration with Stanford University. Stanford GMIX Project Group has visited ZenoWell facilities.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Parasym offers a consumer ear-electrode tVNS device targeting stress, sleep, and anxiety. Directly comparable to ZenoWell on modality (auricular vagus stimulation), customer use cases, and D2C wellness positioning.

TypeBroad incumbent
Description

Muse is a consumer EEG brain-sensing headband for meditation, focus, and sleep. Comparable as a consumer neurotechnology wearable in the wellness channel targeting stress and sleep, though sensing-based rather than stimulation-based.

TypeBroad incumbent
Description

Whoop is a subscription-based wearable for sleep, recovery, and strain tracking. Comparable as a broader incumbent wellness wearable platform targeting sleep and stress/recovery with strong consumer brand and recurring revenue model that ZenoWell currently lacks.

TypeDirect peer
Description

electroCore markets gammaCore, an FDA-cleared non-invasive vagus nerve stimulation device for migraine, cluster headache, and other indications. Closest direct competitor by modality, but differentiated by medical-device clearance and physician channel rather than ZenoWell's wellness D2C positioning.

5Apollo Neuroscience
TypeBroad incumbent
Description

Apollo sells a wearable stress and sleep device that delivers low-frequency vibrations to modulate the nervous system. Comparable as a consumer neuromodulation wellness wearable targeting stress, sleep, and recovery, though using a different stimulation modality than ZenoWell's electrical taVNS.

6Truvaga
TypeDirect peer
Description

Truvaga sells a consumer handheld transcutaneous vagus nerve stimulation device marketed for stress, sleep, and mood. It is the most direct head-to-head competitor to ZenoWell's Luna and Vita, with overlapping ear-electrode delivery, wellness positioning, and D2C channel.

7Neuvana
TypeBroad incumbent
Description

Neuvana sells a consumer earbud-style vagus nerve stimulation device marketed for relaxation, focus, and sleep. Comparable as a consumer VNS wearable in the wellness channel, though positioned through lifestyle/audio use rather than ZenoWell's clinical-research framing.

TypeRegional player
Description

Ceragem manufactures thermal massage and wellness devices, primarily in Asian markets. Comparable at a category level as a consumer wellness-device brand with overlapping lifestyle/health positioning, though focused on thermal therapy rather than vagus nerve stimulation.

TypeEmerging player
Description

Hoolest develops consumer vagus nerve stimulation wearables positioned for performance and stress. Smaller-scale emerging player with overlapping auricular VNS technology and consumer health use cases versus ZenoWell.

TypeBroad incumbent
Description

Oura makes a smart ring for sleep, readiness, and recovery. Comparable as a broader incumbent consumer wearable with strong scientific credibility, recurring subscription revenue, and overlapping sleep/stress use cases that ZenoWell addresses.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers7 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment7 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

ZenoWell

Wearable Neurotechnology Deviceszenowell.ai

ZenoWell designs and sells wearable non-invasive auricular vagus nerve stimulation (taVNS) devices (Luna, Vita) for consumer wellness, targeting sleep, stress, pain, and recovery, and sells globally direct-to-consumer with consumables-based recurring revenue.

What ZenoWell does

ZenoWell is a private neurotechnology company that designs, manufactures, and sells wearable transcutaneous auricular vagus nerve stimulation (taVNS) devices for consumer wellness use. Its core products, the ZenoWell Luna ($409-$499) and ZenoWell Vita ($269-$479), are handheld controllers paired with electrode earpieces that target the auricular branch of the vagus nerve through two innervation-rich sites in the ear (cymba conchae and cavum concha), a configuration the company claims differentiates it from single-site competitors. The technology originated in Prof. Hocher's lab at Heidelberg University and is supported by an in-house research platform called BrainCLOS, developed with Swiss partner BEE Medic, which is used in studies at Cambridge, Heidelberg, and Charité Berlin.

The company monetizes primarily through one-time hardware sales via its own e-commerce storefront (zenowell.ai) with global shipping to the EU, UK, and selected international destinations, supplemented by recurring consumables revenue from replacement electrode earpieces ($129) and conductive gel packs ($59 for a five-month supply). Devices operate standalone without an app or subscription, and the company relies on a multi-channel GTM motion spanning DTC e-commerce, trade shows (CES, IFA, DGPPN, ACAN), community-led education through the Vagus Nerve Society and monthly webinars, and earned media partnerships with outlets including Vogue Italia and Cybernews.

Operationally, ZenoWell is structured as ZENOWELL LIMITED, registered in Hong Kong, with engineering and R&D teams in Heidelberg, Berlin, Shenzhen, and Hong Kong, and research collaborations extending to Stanford. The company holds CE, FCC, and RoHS certifications, reports 2M+ patient sessions with zero serious adverse events in referenced clinical trials, and is led by co-founders Jo Xue (CEO), Dr. Jane Xiao (Chief Scientist), and Prof. Berthold Hocher (Initiator), backed by a scientific advisory board drawn from Heidelberg, Charité, Cambridge, Harvard, Stanford, and CUHK. The most significant recent strategic action is a 2026 cooperation agreement with USound to integrate ultrasound-based physiological sensing into next-generation ear-worn devices, signaling a planned shift from discrete stimulation sessions toward continuous biometric monitoring.

ZenoWell firmographics

Firmographics
Name
ZenoWell
Legal name
ZENOWELL LIMITED
Website
https://zenowell.ai
Company type
Private
Operating status
Operating
Headcount range
11–50 employees
Short description
ZenoWell designs and sells wearable non-invasive auricular vagus nerve stimulation (taVNS) devices (Luna, Vita) for consumer wellness, targeting sleep, stress, pain, and recovery, and sells globally direct-to-consumer with consumables-based recurring revenue.
Ownership category
akta.pro rank

ZenoWell industry classification

Industry
Product category
Wearable Neurotechnology Devices
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
SIC
Electromedical & Electrotherapeutic Apparatus (3845)
akta.pro industry
PRIMARYCRACAQAL
Mental Wellness & Stress Management Devices (Biofeedback, Meditation/Neurostimulation Devices)
Consumer Products & Retail/Consumer Electronics & Appliances Retail/Personal Health & Wellness Devices (Smart Scales, BP/ECG Monitors, Sleep Devices)
SECONDARYCRACAQAK
Posture, Musculoskeletal & Pain-Relief Devices (Posture Trainers, TENS/EMS, Massage Devices)
Consumer Products & Retail/Consumer Electronics & Appliances Retail/Personal Health & Wellness Devices (Smart Scales, BP/ECG Monitors, Sleep Devices)

Keywords

  • Vagus nerve stimulation
  • Wearable neurotechnology
  • Auricular stimulation devices
  • Non-invasive neuromodulation
  • Wellness electronics

Where ZenoWell is headquartered

Location

Headquarters

HQ city
Potsdam
HQ country
Germany
HQ region
Europe

Offices6 records

Markets served

ZenoWell business model

Business model
GTM type
B2C
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations

Revenue model

  1. Hardware Device Sales: One-time purchase of taVNS devices (Luna and Vita) with no ongoing subscription required. Standalone operation without app dependency. Accessory purchases for consumables and replacements
  2. Accessories and Consumables: Replacement earpieces ($129), conductive gel packs ($59), warranty cards. Ongoing revenue from consumables with 5-month supply cycle per gel pack

Pricing tiers

ModelBillingPrice
One time/ perpetual licensePay-as-you-goZenoWell Vita - Entry-level taVNS device
One time/ perpetual licensePay-as-you-goZenoWell Luna - Advanced taVNS device
Unit PricingPay-as-you-goElectrode Earpiece - Replacement accessory
Unit PricingPay-as-you-goGel Pack - Conductive gel consumable
One time/ perpetual licensePay-as-you-goWarranty Card Extension

Go-to-market motion3 records

Distribution channels3 records

Marketing channels8 records

ZenoWell product offering

Product offering

Core offering

ZenoWell designs, manufactures, and sells wearable non-invasive transcutaneous auricular vagus nerve stimulation (taVNS) devices — Luna (4 modes, $409 sale) and Vita (3 modes, $269 sale) — paired with proprietary electrode earpieces and conductive gel consumables. The devices stimulate the auricular branch of the vagus nerve via the ear to address sleep, stress, headache, fatigue, and recovery concerns. The company operates a direct-to-consumer e-commerce store (zenowell.ai) shipping globally with no subscription or app required for device operation.

Product overview

ZenoWell offers a portfolio of wearable non-invasive transcutaneous auricular vagus nerve stimulation (taVNS) devices. The core products are ZenoWell Luna and ZenoWell Vita, both handheld controller devices paired with electrode earpieces that stimulate the auricular branch of the vagus nerve through the ear. Luna features four modes (Relief, Sleep, Relax, Medit) with 8-hour battery life for headache, sleep, stress, and pain applications, while Vita offers three modes (Sleep, Relax, Meditation) with 4-hour battery life focused on sleep and relaxation. Both devices use conductive gel with their earpieces and are accompanied by consumable gel packs. The ecosystem is supported by the BrainCLOS research platform providing clinical-grade studies for healthcare professionals. The company originated from Heidelberg University and collaborates with institutions including Harvard and Cambridge.

Differentiator

Problem solved

Functional benefit

Brands

  • BrainCLOS: Research-grade vagus nerve stimulation system developed in collaboration with BEE Medic Switzerland, used in clinical studies at Cambridge University, Heidelberg University, and Charité Berlin

Products and services

  • ZenoWell Luna Advanced wearable non-invasive transcutaneous auricular vagus nerve stimulation (taVNS) device with four modes (Relief, Sleep, Relax, Medit) designed for headache relief, sleep improvement, stress reduction, and pain/fatigue management. Features 8-hour battery supporting 24 sessions and targets the auricular branch of the vagus nerve via a paired electrode earpiece.
  • ZenoWell Vita Wearable non-invasive transcutaneous auricular vagus nerve stimulation (taVNS) device with three modes (Sleep, Relax, Meditation) designed to enhance sleep, reduce stress and tension, and alleviate fatigue by stimulating the auricular branch of the vagus nerve. Features 4-hour battery supporting 12 sessions.
  • ZenoWell Electrode Earpiece

Quantifiable outcome

  • 25% deeper sleep, 45% less stress, 12% higher HRV, 30% less headache discomfort
  • +5 more outcomes

Companies that use ZenoWell

Customer profile

Named customers7 records

Segments7 records

Ideal customer profiles2 records

ZenoWell technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

ZenoWell partnerships and signals

Strategic signal

Partnerships

Eight partnerships are on record, tiered core and minor.

  • USoundcoreTechnology or Integration · 26 March 2026Strategic cooperation to explore integration of USound's advanced MEMS-based sensing technologies into next-generation wearable health devices. Collaboration aims to combine USound's ultrasound-based physiological sensing capabilities with ZenoWell's ear-based vagus nerve stimulation platform to enable continuous biometric monitoring for sleep, pain, anxiety, and mental health applications. USound holds over 500 patents protecting its MEMS loudspeaker and ultrasound sensing technology.
  • G-PACT (Gastroparesis Awareness)minorGTM or Marketing Partner · 1 January 2026Partnership to promote GI health education during Gastroparesis Awareness Month. Collaborative educational initiatives for gut-brain axis awareness.
  • BEE Medic (Switzerland)coreStrategic or Co-development PartnerCollaboration to bring ZenoWell's vision to life. Together with BEE Medic, they launched the first research-grade system: BrainCLOS, which became part of studies at Cambridge University, Heidelberg University, and Charité Berlin.
  • Heidelberg UniversitycoreStrategic or Co-development PartnerOrigin of ZenoWell technology from Prof. Hocher's lab at Heidelberg University. Ongoing research collaboration with academic institution.
  • Charité BerlincoreStrategic or Co-development PartnerResearch collaboration with Charité University Medicine Berlin. Prof. Pommer from Charité is part of the scientific advisory board.
  • Cambridge UniversitycoreStrategic or Co-development PartnerAcademic research collaboration with Cambridge University. Prof. Voon from Cambridge is part of the scientific advisory board.
  • Vagus Nerve SocietyminorStrategic or Co-development PartnerAffiliation with Vagus Nerve Society (vnsociety.org) for professional networking and knowledge sharing in the VNS field.
  • Stanford UniversityminorStrategic or Co-development PartnerResearch collaboration with Stanford University. Stanford GMIX Project Group has visited ZenoWell facilities.

Scale indicators6 records

Recent moves6 records

Expansion highlights6 records

ZenoWell competitors and assessment

Company assessment

Direct peers

  • Parasym: Parasym offers a consumer ear-electrode tVNS device targeting stress, sleep, and anxiety. Directly comparable to ZenoWell on modality (auricular vagus stimulation), customer use cases, and D2C wellness positioning.
  • electroCore: electroCore markets gammaCore, an FDA-cleared non-invasive vagus nerve stimulation device for migraine, cluster headache, and other indications. Closest direct competitor by modality, but differentiated by medical-device clearance and physician channel rather than ZenoWell's wellness D2C positioning.
  • Truvaga: Truvaga sells a consumer handheld transcutaneous vagus nerve stimulation device marketed for stress, sleep, and mood. It is the most direct head-to-head competitor to ZenoWell's Luna and Vita, with overlapping ear-electrode delivery, wellness positioning, and D2C channel.

Broad incumbents

  • Muse (Interaxon): Muse is a consumer EEG brain-sensing headband for meditation, focus, and sleep. Comparable as a consumer neurotechnology wearable in the wellness channel targeting stress and sleep, though sensing-based rather than stimulation-based.
  • Whoop: Whoop is a subscription-based wearable for sleep, recovery, and strain tracking. Comparable as a broader incumbent wellness wearable platform targeting sleep and stress/recovery with strong consumer brand and recurring revenue model that ZenoWell currently lacks.
  • Apollo Neuroscience: Apollo sells a wearable stress and sleep device that delivers low-frequency vibrations to modulate the nervous system. Comparable as a consumer neuromodulation wellness wearable targeting stress, sleep, and recovery, though using a different stimulation modality than ZenoWell's electrical taVNS.
  • Neuvana: Neuvana sells a consumer earbud-style vagus nerve stimulation device marketed for relaxation, focus, and sleep. Comparable as a consumer VNS wearable in the wellness channel, though positioned through lifestyle/audio use rather than ZenoWell's clinical-research framing.
  • Oura: Oura makes a smart ring for sleep, readiness, and recovery. Comparable as a broader incumbent consumer wearable with strong scientific credibility, recurring subscription revenue, and overlapping sleep/stress use cases that ZenoWell addresses.

Regional players

  • Ceragem: Ceragem manufactures thermal massage and wellness devices, primarily in Asian markets. Comparable at a category level as a consumer wellness-device brand with overlapping lifestyle/health positioning, though focused on thermal therapy rather than vagus nerve stimulation.

Emerging players

  • Hoolest Performance Technologies: Hoolest develops consumer vagus nerve stimulation wearables positioned for performance and stress. Smaller-scale emerging player with overlapping auricular VNS technology and consumer health use cases versus ZenoWell.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

ZenoWell social profiles

Digital presence

ZenoWell compliance and trust

Trust signal

Compliance3 records

ZenoWell financial estimates

Financial estimate

Revenue estimate

Valuation estimate

ZenoWell leadership team

Management profile

Number of profiles

Profiles3 records

ZenoWell funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

ZenoWell M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ZenoWell

What does ZenoWell do?

ZenoWell designs, manufactures, and sells wearable non-invasive transcutaneous auricular vagus nerve stimulation (taVNS) devices — Luna (4 modes, $409 sale) and Vita (3 modes, $269 sale) — paired with proprietary electrode earpieces and conductive gel consumables. The devices stimulate the auricular branch of the vagus nerve via the ear to address sleep, stress, headache, fatigue, and recovery concerns. The company operates a direct-to-consumer e-commerce store (zenowell.ai) shipping globally with no subscription or app required for device operation.

Is ZenoWell a public or private company?

ZenoWell is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was ZenoWell founded?

ZenoWell was founded in -1. It employs 11 to 50 people.

Where is ZenoWell based?

ZenoWell is headquartered in Potsdam, Germany, in the Europe region.

How does ZenoWell make money?

Two revenue lines are on record. Hardware Device Sales are the primary driver. The others are accessories and Consumables.

Who are ZenoWell's main competitors?

Direct peers on record are Parasym, electroCore and Truvaga. Broad incumbents are Muse (Interaxon), Whoop, Apollo Neuroscience, Neuvana and Oura. Ceragem is listed as a regional player. Hoolest Performance Technologies is listed as an emerging player.

Does ZenoWell have an API?

No public API is recorded for ZenoWell.

What industry is ZenoWell in?

ZenoWell's product category is Wearable Neurotechnology Devices. Its primary akta.pro industry code is CRACAQAL, Mental Wellness & Stress Management Devices (Biofeedback, Meditation/Neurostimulation Devices), with a secondary code of CRACAQAK, Posture, Musculoskeletal & Pain-Relief Devices (Posture Trainers, TENS/EMS, Massage Devices). Its NAICS code is 334510 and its SIC code is 3845.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireZenoWell Joins Sleep Europe 2026 to Present Its Smart Sleep DeviceZenoWell will present its Luna Plus Set at Sleep Europe 2026 in Maastricht, a drug-free connected system combining a taVNS ear device, a wearable, and an AI Coach. The system uses vagus nerve stimulation to support sleep, with data tracking and personalized guidance. The company aims to help users refine sleep routines over time.EIN PresswireSleep Technology Is Moving Beyond Monitoring: ZenoWell Explores taVNS for Sleep CareZenoWell is introducing a closed-loop taVNS sleep system with a stimulator, wearable band, and AI coach. The system combines physiological tracking, personalized insights, and a 20-minute pre-bed stimulation session. The company will showcase it at Sleep Europe 2026, citing clinical trials showing sleep quality improvements.Tech.euBeyond the robot dogs: European startups worth watching from IFA 2026Four European consumer hardware startups are highlighted from IFA 2026: BP Relax, LeydenJar, Repartly, and Unistellar. LeydenJar raised over €100 million for silicon anodes, while Repartly has served over 11,000 customers. The startups aim to address health, battery, repair, and astronomy.EIN PresswireLife-changing emerging tech for health, emotional support & well-being will launch at ShowStoppers® @ IFA 2026ShowStoppers @ IFA 2026 will launch emerging health and well-being tech on September 3 in Berlin, with over 120 companies exhibiting. Notable launches include Ascentiz's modular exoskeleton, Everthine's AI companion, and KiWear's smart ring. The event moves to Hall 5.3 at Messe Berlin.AijournZenoWell Unveils Luna Plus: An AI-Driven Vagus Nerve Ecosystem for Your Personalized Life ModelZenoWell, a neurotechnology company incubated at Heidelberg University Medical School, launched the global pre-order of Luna Plus, a next-generation wearable system combining non-invasive vagus nerve stimulation (VNS) with continuous biometric tracking. The three-part product suite integrates the Luna Plus ear wearable, ZenoBand MOBI or compatible third-party devices, and a multi-modal AI coach powered by RAG technology to provide personalized nervous system care. The Luna Plus Set is now available for global pre-order with exclusive early-bird pricing at zenowell.ai.PR NewswireZenoWell Unveils Luna Plus: An AI-Driven Vagus Nerve Ecosystem for Your Personalized Life ModelZenoWell, a neurotechnology company incubated at Heidelberg University Medical School, has launched global pre-orders for Luna Plus, an AI-driven wearable system that combines non-invasive vagus nerve stimulation (VNS) with continuous biometric tracking. The three-part product suite includes a VNS ear wearable with six clinical modes, a compatible smart band or third-party wearable tracker, and a multi-modal AI coach powered by RAG technology to deliver personalized nervous system care recommendations. The Luna Plus Set is available for pre-order at zenowell.ai with early-bird pricing, targeting consumers seeking integrated solutions for sleep, stress, and recovery.TrendHunter.comNext-Generation Vagus Nerve WearablesZenoWell, a neurotechnology company incubated at Heidelberg University Medical School, has launched global pre-orders for Luna Plus — a wearable device combining non-invasive vagus nerve stimulation with biometric tracking and AI-powered coaching. The three-part system includes a stimulation device with six clinically calibrated modes, a MOBI Smart Band or compatible third-party wearables for real-time physiological data, and a multi-modal AI coach that provides personalized recommendations based on biometric trends. The launch targets the fragmented consumer wellness market by offering integrated feedback on stimulation effects alongside measurable biometric data.TrendHunter.comVagus Nerve Stimulation DevicesZenoWell, a medical technology company that originated from Heidelberg University Medical School, has expanded its wearable auricular vagus nerve stimulation devices Luna and Vita into a network of 100 specialty clinics and therapy centers across Europe, North America, Asia, and Oceania. The expansion targets the physiotherapy and alternative wellness sectors, with the devices being integrated into boutique clinics, rehab studios, functional health centers, and independent therapy practices that address conditions including stress dysregulation, sleep disorders, anxiety, chronic pain, and gut health issues. The company is positioning itself at the intersection of digital health, wearable neuromodulation, and the growing gut-brain wellness trend.audioXpressUSound Announces Strategic Cooperation with ZenoWell to Explore Advanced Sensing Technologies for Next-Generation Wearable DevicesUSound announced a strategic cooperation with ZenoWell to explore the integration of USound's advanced sensing technologies, including ultrasound-based physiological sensing, into ZenoWell's next-generation wearable neurotechnology devices. The partnership aims to leverage the ear as a promising site for biometric monitoring and combine sensing capabilities with ZenoWell's existing ear-based vagus nerve stimulation platform. Both companies stated the collaboration could enable more personalized health solutions for sleep, pain, anxiety, and mental health challenges.openPR.comZenoWell Announces Strategic Cooperation with USound to Explore Advanced Sensing Technologies for Next-Generation Wearable DevicesZenoWell, a wearable neurotechnology company based in Heidelberg, Germany, announced a strategic cooperation with USound, a global leader in miniaturized audio systems built on MEMS technology, to explore the integration of USound's advanced sensing technologies into next-generation wearable devices. The collaboration aims to leverage the ear as a promising site for physiological sensing, combining USound's ultrasound technology with ZenoWell's existing ear-based vagus nerve stimulation platform to develop more personalized health solutions for monitoring sleep, stress, and nervous system balance.